Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 8208904, 5 pages
http://dx.doi.org/10.1155/2016/8208904
Research Article

Expression of Migration-Related Genes in Human Colorectal Cancer and Activity of a Disintegrin and Metalloproteinase 17

1Department of Internal Medicine, Faculty of Public Health in Bytom, Medical University of Silesia, 40-055 Katowice, Poland
2Department of Molecular Biology, Faculty of Pharmacy in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland

Received 24 October 2015; Accepted 22 February 2016

Academic Editor: Dimitrios Dimitroulis

Copyright © 2016 Katarzyna Walkiewicz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Wideł and M. Wideł, “Mechanisms of metastasis and molecular markers of malignant tumor progression. I. Colorectal cancer,” Postȩpy Higieny i Medycyny Doświadczalnej, vol. 60, pp. 453–470, 2006. View at Google Scholar · View at Scopus
  2. A. Harlozińska-Szmyrka and E. Sobańska, “Przerzuty nowotworowe—terrorysta XXI wieku,” Przewodnik Lekarza, vol. 1, pp. 19–27, 2008. View at Google Scholar
  3. A. Popow-Woźniak, D. Nowak, and M. Malicka-Błaszkiewicz, “Sposoby migracji komórek nowotworowych,” Postępy Biochemii, vol. 1, pp. 113–170, 2009. View at Google Scholar
  4. R. Paduch, “Przerzut nowotworowy—znaczenie agregacji komórek nowotworowych z płytkami krwi,” Onkologia Polska, vol. 8, no. 4, pp. 229–238, 2005. View at Google Scholar
  5. J. Naduk-Kik and E. Hrabec, “Udział metaloproteinaz macierzy w patogenezie cukrzycy i rozwoju retinopatii cukrzycowej,” Postępy Higieny i Medycyny Doświadczalnej, vol. 62, pp. 442–450, 2008. View at Google Scholar
  6. M. Łukaszewicz-Zając, B. Mroczko, and M. Szmitkowski, “Znaczenie metaloproteinaz oraz ich inhibitorów w raku żołądka,” Postępy Higieny i Medycyny Doświadczalnej, vol. 63, pp. 258–265, 2009. View at Google Scholar
  7. M. Łukaszewicz, B. Mroczko, and M. Szmitkowski, “Rola metaloproteinaz i ich inhibitorów w raku trzustki,” Postępy Higieny i Medycyny Doświadczalnej, vol. 62, pp. 141–147, 2008. View at Google Scholar
  8. P. Kwiatkowski, J. Godlewski, A. Śliwińska-Jewsiewicka, and Z. Kmieć, “Cząsteczki adhezyjne w procesie nowotworzenia i przerzutowania,” Polish Annals of Medicine, vol. 16, no. 1, pp. 128–137, 2008. View at Google Scholar
  9. I. Śliwowska and Z. Kopczyński, “Metaloproteinazy macierzy zewnątrzkomórkowej—charakterystyka biochemiczna i kliniczna wartość oznaczania u chorych na raka piersi,” Współczesna Onkologia, vol. 9, no. 8, pp. 327–335, 2005. View at Google Scholar
  10. J. Bogaczewicz, W. Dudek, T. Zubilewicz et al., “Rola metaloproteaz macierzy i ich tkankowych inhibitorów w angiogenezie,” Postępy Higieny i Medycyny Doświadczalnej, vol. 40, pp. 80–85, 2006. View at Google Scholar
  11. F. Blanchot-Jossic, A. Jarry, D. Masson et al., “Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells,” Journal of Pathology, vol. 207, no. 2, pp. 156–163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. M. Smalley and K. Ley, “L-selectin: mechanisms and physiological significance of ectodomain cleavage,” Journal of Cellular and Molecular Medicine, vol. 9, no. 2, pp. 255–266, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. E. L. Hassemer, B. Endres, J. A. Toonen, A. Ronchetti, R. Dubielzig, and D. J. Sidjanin, “ADAM17 transactivates EGFR signaling during embryonic eyelid closure,” Investigative Ophthalmology and Visual Science, vol. 54, no. 1, pp. 132–140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Aydin, A. Bilici, D. Yavuzer et al., “Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy,” Clinical and Translational Oncology, vol. 17, no. 8, pp. 604–611, 2015. View at Publisher · View at Google Scholar
  15. P. M. McGowan, E. McKiernan, F. Bolster et al., “ADAM-17 predicts adverse outcome in patients with breast cancer,” Annals of Oncology, vol. 19, no. 6, pp. 1075–1081, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Makrodouli, E. Oikonomou, M. Koc et al., “BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study,” Molecular Cancer, vol. 10, article 118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Hsi-Hsien, H. Wei-Syun, L. Yueh-Min et al., “JNK suppression is essential for 17β-Estradiol inhibits prostaglandin E2-Induced uPA and MMP-9 expressions and cell migration in human LoVo colon cancer cells,” Journal of Biomedical Science, vol. 18, article 61, 12 pages, 2011. View at Publisher · View at Google Scholar
  18. H. Kang, S. W. Jang, and J. Ko, “Human leucine zipper protein sLZIP induces migration and invasion of cervical cancer cells via expression of matrix metalloproteinase-9,” The Journal of Biological Chemistry, vol. 286, no. 49, pp. 42072–42081, 2011. View at Publisher · View at Google Scholar
  19. Z.-S. Zeng, A. M. Cohen, and J. G. Guillem, “Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis,” Carcinogenesis, vol. 20, no. 5, pp. 749–755, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. R. A. Black, C. T. Rauch, and J. J. Kozlosky, “A metalloproteinase disintegrin that releases tumour necrosis factor-α,” Nature, vol. 385, pp. 733–736, 1997. View at Google Scholar
  21. M. J. Duffy, E. McKiernan, N. O'Donovan, and P. M. McGowan, “Role of ADAMs in cancer formation and progression,” Clinical Cancer Research, vol. 15, no. 4, pp. 1140–1144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Muc-Wierzgon, E. Nowakowska-Zajdel, T. Kokot et al., “Genetic disregulation of gene coding tumor necrosis factor α receptors (TNFαRs) in colorectal cancer cells,” Journal of Experimental & Clinical Cancer Research, vol. 23, no. 4, pp. 651–660, 2004. View at Google Scholar
  23. M. Muc-Wierzgon, E. Nowakowska-Zajdel, T. Kokot et al., “Genetic disregulation of TNFα type II receptors in colon cancer at the II and III stage of disease,” Journal of Biological Regulators and Homeostatic Agents, vol. 20, no. 1-2, pp. 10–14, 2006. View at Google Scholar
  24. N. I. Herath and A. W. Boyd, “The role of Eph receptors and ephrin ligands in colorectal cancer,” International Journal of Cancer, vol. 126, no. 9, pp. 2003–2011, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Saito, N. Masuda, T. Miyazaki et al., “Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis,” Oncology Reports, vol. 11, no. 3, pp. 605–611, 2004. View at Google Scholar · View at Scopus